CEO Thomas Braun speaks to CNN anchor Ali Velshi about using Verisante Aura™ for skin cancer detection on the Big I (Idea, Innovation and Imagination).
VRS on the TSX Venture Exchange $ 0.36
Verisante on Fox News
See Video ClipCEO Thomas Braun is interviewed on Fox News by anchor Tracy Byrnes about Verisante's revolutionary Aura device and platform technology.
Verisante in Financial Post
See ArticleThomas Braun discusses the "Secrets of Selling Medical Devices", and the commercialization process of Verisante Aura™, as featured in the Financial Post on August 23, 2011.
Verisante is developing innovative systems for the early detection of many forms of cancer using technology developed by the BC Cancer Agency and the University of British Columbia.
Learn More
The Verisante Core™ series uses the platform technology behind Verisante Aura™ and an en- doscopic attachment to aid in the early detection of lung, colon, cervical and other cancers.
Learn More
